The FDA closes a huge loophole used by bogus stem-cell clinics, but delays serious enforcement for 3 years – Los Angeles Times
Los Angeles Times |
The FDA closes a huge loophole used by bogus stem–cell clinics, but delays serious enforcement for 3 years
Los Angeles Times There was good news and bad news in the regulatory initiative the Food and Drug Administration rolled out on Thursday, aimed partially at clinics marketing unproven stem–cell therapies directly to consumers. The good news is that the FDA firmly closed … Is The Wild West Of Stem Cell Therapies Coming To An End? FDA warns about stem cell therapies FDA Releases Guidelines On Stem–Cell Treatments |
